CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021
Cash flows from operating activities:
Net income	$ 43,591	$ 29,152
Adjustments to reconcile net (loss)/income to net cash used in operating activities:
Depreciation and amortization	5,635	6,283
Transactional losses/(gains)	41	(497)
Provision for inventories and accounts receivable	1,684	2,128
Deferred income taxes	(1,269)	825
Stock-based compensation	2,761	2,784
Other	129	123
Changes in assets and liabilities:
Trade receivables	(12,274)	(13,245)
Inventories	(59,444)	(33,771)
Other current assets	(3,580)	1,138
Accounts payable	6,920	17,992
Accrued liabilities	11,266	1,515
Accrued payroll and benefits	(13,716)	(4,100)
Income taxes receivable	7,123	17,986
Income taxes payable	(10,661)	(6,317)
Other non-current assets	(3,932)	620
Other non-current liabilities	334	62
Net cash (used in)/provided by operating activities	(25,392)	22,678
Cash flows from investing activities:
Capital expenditures	(2,987)	(1,786)
Long-term investments	(2,283)	0
Trademarks and other intangibles	(57)	(133)
Net cash used in investing activities	(5,327)	(1,919)
Cash flows from financing activities:
Repayment of bank borrowings	0	(21,140)
Dividends paid	(15,797)	(11,618)
Stock repurchase	(21,539)	(9,975)
Stock awards and options exercised and other changes	(405)	(1,030)
Other	(85)	0
Net cash used in financing activities	(37,826)	(43,763)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	(5,489)	(1,096)
Net decrease in cash, cash equivalents and restricted cash	(74,034)	(24,100)
Cash, cash equivalents, and restricted cash at beginning of year	277,716	224,423
Cash, cash equivalents, and restricted cash at end of period	203,682	200,323
Reconciliation of cash, cash equivalents, and restricted cash:
Cash and cash equivalents	203,109	199,721
Restricted cash included in other non-current assets	573	602
Cash, cash equivalents, and restricted cash at end of period	$ 203,682	$ 200,323